U.S. markets close in 7 minutes

Baxter International Inc. (BAX)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
75.27-0.76 (-1.00%)
As of 3:53PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close76.03
Open76.15
Bid75.31 x 1400
Ask75.33 x 800
Day's Range75.20 - 76.13
52 Week Range69.10 - 95.19
Volume1,339,101
Avg. Volume3,089,478
Market Cap38.449B
Beta (5Y Monthly)0.73
PE Ratio (TTM)42.60
EPS (TTM)1.77
Earnings DateOct 29, 2020
Forward Dividend & Yield0.98 (1.29%)
Ex-Dividend DateDec 03, 2020
1y Target Est94.35
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-31% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill/Finish Manufacturing Site in Bloomington, Ind.
    Business Wire

    Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill/Finish Manufacturing Site in Bloomington, Ind.

    Baxter announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, Ind.

  • Baxter Announces U.S. FDA 510(k) Clearance of Homechoice Claria with Sharesource
    Business Wire

    Baxter Announces U.S. FDA 510(k) Clearance of Homechoice Claria with Sharesource

    Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of the Homechoice Claria automated peritoneal dialysis (APD) system with Sharesource connectivity platform. Homechoice Claria combines a simple user interface with the benefits of Sharesource, the only two-way remote patient management platform for patients on peritoneal dialysis in the U.S. Homechoice Claria is cleared for both adult and pediatric populations.1 The clearance follows the recent finalization of the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) payment model, which aims to significantly increase the number of new patients with kidney failure who receive home dialysis and/or organ transplants.

  • Baxter to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
    Business Wire

    Baxter to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference

    Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 3rd Annual HealthCONx virtual conference via webcast on Tuesday, December 1, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 11:20 a.m. Eastern Time.